SCHRODER INVESTMENT MANAGEMENT GROUP
Position in BMY — Bristol Myers Squibb Co
CIK 1086619
London, X0
Position in BMY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$742,082,707
+$64,900,424 QoQ
Shares Held
12,235,494
-2.5% QoQ
Ownership
0.599%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $4,239,983,804 across 11 Drug Manufacturers - General names. BMY ranks #3 (17.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,169,027 | $1,075,235,958 | |
| 2 | JNJ |
Johnson & Johnson
|
3,844,298 | $939,700,197 | |
| 3 | BMY |
Bristol Myers Squibb Co
This page
|
12,235,494 | $742,082,707 | |
| 4 | ABBV |
AbbVie Inc.
|
2,216,285 | $482,019,823 | |
| 5 | PFE |
Pfizer Inc
|
12,595,834 | $353,691,016 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,585,507 | $220,972,107 | |
| 7 | MRK |
Merck & Co., Inc.
|
1,756,247 | $211,258,948 | |
| 8 | AMGN |
Amgen Inc
|
564,067 | $198,466,971 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $742,082,707 | 12,235,494 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $677,182,283 | 12,554,362 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $548,821,490 | 12,168,991 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $633,897,987 | 13,694,059 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $616,621,338 | 10,110,204 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $645,543,484 | 11,413,428 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $394,587,501 | 7,626,353 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $277,152,611 | 6,673,552 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $247,955,770 | 4,572,299 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $177,836,146 | 3,465,916 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $160,685,360 | 2,768,528 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $222,892,667 | 3,485,421 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $549,288,676 | 7,925,100 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $664,319,668 | 9,233,074 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $683,331,861 | 9,612,208 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $766,153,157 | 9,950,041 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $644,588,119 | 8,826,347 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $499,531,113 | 8,011,726 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $420,956,500 | 7,114,357 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $450,623,653 | 6,743,844 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $332,875,459 | 5,272,857 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $280,715,769 | 4,525,484 | Shares | Sole | 2021-02-24 | |
| 2020-09-30 | $277,688,079 | 4,605,873 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $267,123,695 | 4,542,920 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $249,840,109 | 4,482,241 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||